Escitalopram Oxalate
Product Images NDC 50090-2752

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 50090-2752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Escitalopram Oxalate Tablets 1)

This is a table that shows the treatment-emergent adverse reactions observed with a frequency greater than 2% and higher than the placebo for major depressive disorder. It includes the percentage of occurrence for each reaction for the drug Escitalopram Oxalate compared to the placebo, such as dry mouth, sweating, diarrhea, indigestion, fatigue, insomnia, sinusitis, and others. It also provides additional information regarding the denominator used for males and females.*

FDA Label Image

2 (Escitalopram Oxalate Tablets 2)

The table shows the most common adverse reactions observed in patients taking Escitalopram for Generalized Anxiety Disorder. The adverse reactions are primarily related to the nervous system, the gastrointestinal system, and psychiatric disorders. The most common adverse reactions with a frequency greater than placebo are dry mouth, increased sweating, headache, nausea, somnolence, and ejaculation disorder.*

FDA Label Image

1 (Escitalopram Oxalate Tablets 3)

FDA Label Image

Logo (Escitalopram Oxalate Tablets 4)

FDA Label Image

1 (Escitalopram Oxalate Tablets 5)

FDA Label Image

Label Image (Lbl500902752)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.